News

Dr Kate Holmes, Research Manager at The Prostate Cancer Charity, spoke to the Daily Mail, the Daily Telegraph, The Guardian and BBC News Online about a new and reliable urine test which can detect whether men are at high risk of developing prostate cancer.

John Neate, Chief Executive at The Prostate Cancer Charity, spoke to the Daily Telegraph, BBC Online and The Sun about the preliminary results of a trial of almost 800 men who took abiraterone acetate and lived almost four months longer than men given a placebo.

Our comments on new research from the University of Illinois which suggests that the chemical Bisphenol A, used in the production of plastics, can increase the risk of developing prostate cancer in rats.

We comment on new research published in The Lancet into a new drug, cabazitaxel, which can extend the lives of men with advanced prostate cancer that no longer responds to hormone therapies by an average of 2.4 months.